• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Using patients like my patient for clinical decision support: institution-specific probability of celiac disease diagnosis using simplified near-neighbor classification.使用像我这样的患者进行临床决策支持:使用简化的近邻分类法对乳糜泻进行机构特异性诊断的概率。
J Gen Intern Med. 2013 Dec;28(12):1565-72. doi: 10.1007/s11606-013-2443-z. Epub 2013 May 4.
2
Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.血清转谷氨酰胺酶和肌内膜抗体检测无法检出大多数采用无麸质饮食的乳糜泻和持续性绒毛萎缩患者:一项荟萃分析。
Gastroenterology. 2017 Sep;153(3):689-701.e1. doi: 10.1053/j.gastro.2017.05.015. Epub 2017 May 22.
3
Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without Biopsy.基于抗体的策略在儿科乳糜泻诊断中的验证:无需活检。
Gastroenterology. 2017 Aug;153(2):410-419.e17. doi: 10.1053/j.gastro.2017.04.023. Epub 2017 Apr 28.
4
Defining thresholds of antibody levels improves diagnosis of celiac disease.定义抗体水平的阈值可提高乳糜泻的诊断。
Clin Gastroenterol Hepatol. 2013 Apr;11(4):398-403; quiz e32. doi: 10.1016/j.cgh.2012.10.025. Epub 2012 Oct 25.
5
Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease.十种第二代(人)组织转谷氨酰胺酶抗体检测方法在乳糜泻中的诊断准确性。
Clin Chem. 2004 Nov;50(11):2125-35. doi: 10.1373/clinchem.2004.035832. Epub 2004 Sep 23.
6
Positive tissue transglutaminase antibodies with negative endomysial antibodies: Unresolved issues in diagnosing celiac disease.组织转谷氨酰胺酶抗体阳性而内肌层抗体阴性:诊断乳糜泻中的未解决问题。
J Immunol Methods. 2021 Feb;489:112910. doi: 10.1016/j.jim.2020.112910. Epub 2020 Nov 7.
7
Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice.临床实践中无活检测情况下对乳糜泻的诊断准确性。
Gastroenterology. 2017 Oct;153(4):924-935. doi: 10.1053/j.gastro.2017.06.002. Epub 2017 Jun 15.
8
Are positive serum-IgA-tissue-transglutaminase antibodies enough to diagnose coeliac disease without a small bowel biopsy? Post-test probability of coeliac disease.血清 IgA 阳性组织转谷氨酰胺酶抗体足以诊断乳糜泻而无需小肠活检吗?乳糜泻的后验概率。
J Crohns Colitis. 2012 Sep;6(8):861-6. doi: 10.1016/j.crohns.2012.01.016. Epub 2012 Feb 15.
9
AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review.AGA 临床实践更新:乳糜泻的诊断和监测——血清学和组织学检测的效用变化:专家评论。
Gastroenterology. 2019 Mar;156(4):885-889. doi: 10.1053/j.gastro.2018.12.010. Epub 2018 Dec 19.
10
Value of biopsy in a cohort of children with high-titer celiac serologies: observation of dynamic policy differences between Europe and North America.高滴度乳糜泻血清学患儿活检的价值:观察欧洲和北美之间动态政策差异。
BMC Health Serv Res. 2020 Oct 20;20(1):962. doi: 10.1186/s12913-020-05815-0.

引用本文的文献

1
Risk Factors for Non-O157 Shiga Toxin-Producing Escherichia coli Infections, United States.非 O157 型志贺毒素产大肠埃希氏菌感染的危险因素,美国。
Emerg Infect Dis. 2023 Jun;29(6):1183-1190. doi: 10.3201/eid2906.221521.
2
Clinical laboratory analytics: Challenges and promise for an emerging discipline.临床实验室分析:一门新兴学科面临的挑战与前景
J Pathol Inform. 2015 Feb 24;6:9. doi: 10.4103/2153-3539.151919. eCollection 2015.
3
Medicine based upon data.基于数据的医学。
J Gen Intern Med. 2013 Dec;28(12):1545-6. doi: 10.1007/s11606-013-2549-3.

本文引用的文献

1
Shared decision making: a model for clinical practice.共同决策:一种临床实践模式。
J Gen Intern Med. 2012 Oct;27(10):1361-7. doi: 10.1007/s11606-012-2077-6. Epub 2012 May 23.
2
Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report.儿童乳糜泻诊断性抗体检测的准确性:证据报告摘要。
J Pediatr Gastroenterol Nutr. 2012 Feb;54(2):229-41. doi: 10.1097/MPG.0b013e318216f2e5.
3
European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease.欧洲儿科胃肠病学、肝病学和营养学学会关于乳糜泻诊断的指南。
J Pediatr Gastroenterol Nutr. 2012 Jan;54(1):136-60. doi: 10.1097/MPG.0b013e31821a23d0.
4
Variability in small bowel histopathology reporting between different pathology practice settings: impact on the diagnosis of coeliac disease.不同病理实践环境中小肠组织病理学报告的变异性:对乳糜泻诊断的影响。
J Clin Pathol. 2012 Mar;65(3):242-7. doi: 10.1136/jclinpath-2011-200372. Epub 2011 Nov 12.
5
Calibrating predictive model estimates to support personalized medicine.校准预测模型估计值以支持个性化医疗。
J Am Med Inform Assoc. 2012 Mar-Apr;19(2):263-74. doi: 10.1136/amiajnl-2011-000291. Epub 2011 Oct 7.
6
Do gastroenterologists adhere to diagnostic and treatment guidelines for celiac disease?消化内科医生是否遵循乳糜泻的诊断和治疗指南?
J Clin Gastroenterol. 2012 Feb;46(2):e12-20. doi: 10.1097/MCG.0b013e31822f0da0.
7
Adaptive informatics for multifactorial and high-content biological data.多因素和高内涵生物学数据的自适应信息学。
Nat Methods. 2011 Jun;8(6):487-93. doi: 10.1038/nmeth.1600. Epub 2011 Apr 24.
8
A novel algorithm for the diagnosis of celiac disease and a comprehensive review of celiac disease diagnostics.一种用于诊断乳糜泻的新算法及乳糜泻诊断的全面综述。
Clin Rev Allergy Immunol. 2012 Jun;42(3):331-41. doi: 10.1007/s12016-010-8250-y.
9
Update on serologic testing in celiac disease.对乳糜泻血清学检测的最新研究进展。
Am J Gastroenterol. 2010 Dec;105(12):2520-4. doi: 10.1038/ajg.2010.276.
10
Interventions for improving the adoption of shared decision making by healthcare professionals.提高医疗保健专业人员采用共同决策的干预措施。
Cochrane Database Syst Rev. 2010 May 12(5):CD006732. doi: 10.1002/14651858.CD006732.pub2.

使用像我这样的患者进行临床决策支持:使用简化的近邻分类法对乳糜泻进行机构特异性诊断的概率。

Using patients like my patient for clinical decision support: institution-specific probability of celiac disease diagnosis using simplified near-neighbor classification.

机构信息

Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA,

出版信息

J Gen Intern Med. 2013 Dec;28(12):1565-72. doi: 10.1007/s11606-013-2443-z. Epub 2013 May 4.

DOI:10.1007/s11606-013-2443-z
PMID:23645451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3832711/
Abstract

BACKGROUND

Interpretation of a diagnostic test result requires knowing what proportion of patients with a "similar" result has the condition in question. This information is often not readily available from the medical literature, or may be based on different clinical populations that make it nonapplicable. In certain settings, where correlated screening parameters and diagnostic data are available in electronic medical records, a representation of diagnostic test performance on "patients like my patient" can be obtained.

OBJECTIVE

We sought to integrate patient demographic and physician practice information using a simplified nearest neighbor algorithm. We used this method to illustrate the relationship between tTG IgA test result and duodenal biopsy for celiac disease in a local diagnostic context.

PARTICIPANTS

We used a data set of 1,461 paired tissue transglutaminase (tTG) IgA and definitive duodenal biopsy results from Intermountain Healthcare with data on patient age and ordering physician specialty. This was split into a discovery set of 1,000 and a validation set of 461 paired results.

MAIN MEASURES

Accuracy of the local discovery data set in predicting probability of positive duodenal biopsy and confidence intervals around predicted probability in the test data compared to probabilities of positive biopsy implied from published logistic regression and from published sensitivity and specificity studies.

KEY RESULTS

The near-neighbor method could estimate probability of clinical outcomes with predictive performance equivalent to other methods while adjusting probability estimates and confidence intervals to fit specific clinical situations.

CONCLUSIONS

Data from clinical encounters obtained from electronic medical records can yield prediction estimates that are tailored to the individual patient, local population, and healthcare delivery processes. Local analysis of diagnostic probability may be more clinically meaningful than probabilities inferred from published studies. This local utility may come at the expense of external validity and generalizability.

摘要

背景

解释诊断测试结果需要知道具有“相似”结果的患者中有多少比例患有相关疾病。这些信息通常无法从医学文献中直接获得,或者可能基于不同的临床人群,导致其不适用。在某些情况下,如果电子病历中可以获得相关的筛查参数和诊断数据,则可以获得针对“与我患者相似的患者”的诊断测试性能表示。

目的

我们试图使用简化的最近邻算法整合患者人口统计学和医生实践信息。我们在当地的诊断环境中,使用这种方法来说明抗组织转谷氨酰胺酶(tTG)IgA 检测结果与乳糜泻十二指肠活检之间的关系。

参与者

我们使用了来自 Intermountain Healthcare 的 1461 对组织转谷氨酰胺酶(tTG)IgA 和明确的十二指肠活检结果的数据,这些数据包含患者年龄和开单医生专业信息。这些数据被分为发现集(1000 对)和验证集(461 对)。

主要测量指标

本地发现数据集预测阳性十二指肠活检概率的准确性,以及与发表的逻辑回归和发表的灵敏度和特异性研究推断的阳性活检概率相比,在测试数据中预测概率的置信区间。

主要结果

近邻方法可以估计临床结果的概率,预测性能与其他方法相当,同时调整概率估计值和置信区间以适应特定的临床情况。

结论

从电子病历中获取的临床数据可以产生针对个体患者、当地人群和医疗服务提供过程的预测估计。与从发表的研究中推断的概率相比,对诊断概率的本地分析可能更具临床意义。这种本地效用可能会以外部有效性和普遍性为代价。